Qiagen NV (LTS:0RLT)
€ 43.54 0 (0%) Market Cap: 9.28 Bil Enterprise Value: 9.84 Bil PE Ratio: 30.13 PB Ratio: 2.80 GF Score: 88/100

Qiagen NV at Barclays Global Healthcare Conference Transcript

Mar 14, 2019 / 02:15PM GMT
Release Date Price: €36.34 (+0.41%)
Jack Meehan
Barclays Bank PLC, Research Division - Former VP & Senior Research Analyst

We're going to start quickly with 3 audience response questions, so please use the BlackBerrys in front of you.

First, what do you view as QIAGEN's organic growth profile over the next 3 years? Maybe a sneak peek for the Analyst Day. John can give us the answer later.

(Voting)

Jack Meehan
Barclays Bank PLC, Research Division - Former VP & Senior Research Analyst

Mid-single digits, some double digits, some low single.

Question two, do you expect organic growth to accelerate from current levels, and when?

(Voting)

Jack Meehan
Barclays Bank PLC, Research Division - Former VP & Senior Research Analyst

No, and yes, 2020.

And then finally, how would you like to see Peer and Roland and John deploy capital in 2019?

(Voting)

Jack Meehan
Barclays Bank PLC, Research Division - Former VP & Senior Research Analyst

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot